ONCTERNAL THERAPEUTICS, INC.
Profile
Company Names
ONCTERNAL THERAPEUTICS, INC.
GTX INC /DE/
Addresses
12230 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA 92130
175 TOYOTA PLAZA, 7TH FLOOR, MEMPHIS, TN 38103
Phone Numbers
(858) 434-1113
901-523-9700
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$127,990,101.00
Number of Funding Rounds:
8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2020-12-14
$6,467,063.00
$6,467,063.00
$0.00
7
2020-11-20
$1,687,501.00
$1,687,501.00
$0.00
6
2020-09-01
$382,549.00
$382,549.00
$0.00
5
2020-07-17
$3,456,308.00
$3,456,308.00
$0.00
4
2020-05-19
$2,814,260.00
$2,814,260.00
$0.00
3
2017-09-29
$48,499,965.00
$78,175,657.00
$29,675,692.00
Equity
2
2014-11-14
$43,410,000.00
$43,410,000.00
$0.00
Equity
1
2014-03-06
$21,272,455.00
$21,272,455.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
JAMES
B.
BREITMEYER, M.D., PH.D.
DIRECTOR, EXECUTIVE OFFICER
DAVID
F.
HALE
DIRECTOR
SKINMEDICA INC
| SOMAXON PHARMACEUTICALS, INC.
| NEURELIS, INC.
| RIDGE DIAGNOSTICS, INC.
| CONATUS PHARMACEUTICALS INC
| AGILITY CLINICAL, INC.
| COLORESCIENCE INC
| TOKALAS, INC.
| RECROS MEDICA, INC.
| IDUN PHARMACEUTICALS INC
| MDREJUVENA, INC.
| DERMATA THERAPEUTICS, LLC
| ONCTERNAL THERAPEUTICS, INC.
| ADIGICA HEALTH, INC.
| NEURANA PHARMACEUTICALS, INC.
| CLARIFY MEDICAL, INC.
| ONCTERNAL THERAPEUTICS, INC.
WILLIAM
R.
LARUE
DIRECTOR
MITCHELL
S.
STEINER
EXECUTIVE OFFICER, DIRECTOR
RICHARD
VINCENT
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2017-09-29
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2014-11-14
D/A
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2014-03-06
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2014-03-06
